Cycurion is trading 10.05% lower at $3.31, with the specific catalyst unclear.
- No new company-specific announcement explaining the October 6 decline was identified.
- Its latest notable company news was its October 2 announcement that it had regained Nasdaq minimum-bid-price compliance.
- Major U.S. indexes are higher; available evidence does not point to broader market sentiment as the reason for Cycurionβs drop.